| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | US7560440 Endothelial growth factors; antiischemic agents; neovascularization |
| 07/14/2009 | US7560131 High solubility composition with high isoflavone concentration and process of producing same |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | WO2008083357A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | WO2009085651A1 Metal carbonate particles for use in medicine and methods of making thereof |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084531A1 Monosebacate of pyrazole derivative |
| 07/09/2009 | WO2009084501A1 Sultam derivative |
| 07/09/2009 | WO2009083614A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | WO2009083444A1 Composition for the treatment of osteoarthritis |
| 07/09/2009 | WO2009048940A3 Diacerein pharmaceutical formulations |
| 07/09/2009 | WO2008141511A8 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF |
| 07/09/2009 | US20090176873 Novel use of organic compounds |
| 07/09/2009 | US20090176861 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 07/09/2009 | US20090176814 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176785 Method of treating arthritis |
| 07/09/2009 | US20090176769 Cgrp receptor antagonists |
| 07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 07/09/2009 | US20090176693 Agent for maintaining the hardness of tooth structure |
| 07/09/2009 | US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175859 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 07/09/2009 | CA2711141A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710452A1 Imidazo [1,2-a] pyridine compounds |
| 07/09/2009 | CA2708399A1 Composition for the treatment of osteoarthritis |
| 07/08/2009 | EP2077326A1 Novel nucleic acid |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2076266A2 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 07/08/2009 | EP1660108A4 Composition comprising notoginseng radix extract for preventing and treating arthritis as an effective ingredient |
| 07/08/2009 | EP1622926B1 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100509850C Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509022C Plaster for traumatic injuries |
| 07/08/2009 | CN100509020C Plaster for bone disease |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | US7556649 Methods and compositions for treating intervertebral disc degeneration |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/02/2009 | WO2009081833A1 Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009080914A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage |
| 07/02/2009 | WO2009080778A2 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 07/02/2009 | WO2009080749A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases |
| 07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual |
| 07/02/2009 | US20090170952 Colchicine compositions and methods |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170921 Benzimidazole derivatives |
| 07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169595 Controlled Release Polymeric Compositions of Bone Growth Promoting Compounds |
| 07/02/2009 | US20090169592 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169551 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169526 Bmp-6 estrogen responsive element and methods of use thereof |